American Century Companies Inc. Takes $1.36 Million Position in Nutex Health Inc. (NASDAQ:NUTX)

American Century Companies Inc. bought a new position in Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 42,993 shares of the company's stock, valued at approximately $1,362,000. American Century Companies Inc. owned about 0.79% of Nutex Health at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp purchased a new stake in shares of Nutex Health during the 3rd quarter valued at about $225,000. Beaird Harris Wealth Management LLC purchased a new stake in shares of Nutex Health in the 3rd quarter worth $69,000. Drive Wealth Management LLC purchased a new position in Nutex Health during the fourth quarter valued at $1,122,000. Baader Bank Aktiengesellschaft bought a new stake in Nutex Health during the fourth quarter valued at about $206,000. Finally, Legato Capital Management LLC increased its position in Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after buying an additional 6,697 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Maxim Group boosted their price objective on Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

Nutex Health Price Performance

Shares of NASDAQ NUTX traded up $1.04 during mid-day trading on Tuesday, reaching $130.71. The company's stock had a trading volume of 22,783 shares, compared to its average volume of 54,920. Nutex Health Inc. has a 52 week low of $4.16 and a 52 week high of $137.32. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The firm has a market capitalization of $722.59 million, a PE ratio of -13.77 and a beta of 0.27. The stock has a fifty day moving average of $64.12 and a two-hundred day moving average of $42.85.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $11.21. The firm had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

Insider Activity at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the firm's stock in a transaction dated Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at $399,887.28. This represents a 25.72 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 38.52% of the stock is owned by corporate insiders.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.